The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis

@article{Schoeler2015TheEO,
  title={The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis},
  author={Tabea Schoeler and Joseph Kambeitz and Irena Behlke and Robin M. Murray and Sagnik Bhattacharyya},
  journal={Psychological Medicine},
  year={2015},
  volume={46},
  pages={177 - 188}
}
Background. Effect of cannabis use on memory function is a contentious issue, with effects being different in healthy individuals and patients with psychosis. Method. Employing a meta-analytic approach we investigated the effects of cannabis use on memory function in patients with psychosis and healthy individuals, and the effect of diagnosis, memory dimension and moderating factors. A total of 88 studies were identified through a systematic literature search, investigating healthy (n = 7697… Expand
Opposing Effects of Cannabis Use on Late Auditory Repetition Suppression in Schizophrenia Patients and Healthy Control Subjects.
TLDR
Diverging effects of chronic cannabis use on P200 repetition suppression may suggest underlying alterations in the endocannabinoid system in schizophrenia. Expand
Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder
TLDR
Supporting evidence for the trend of superior neurocognitive performance in FES patients with a lifetime history of cannabis use compared to non-using patients is delivered. Expand
Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
TLDR
Significant cognitive differences between patients with CANN+ versus CANN- even at early-onset psychosis are demonstrated, which could suggest a different underlying mechanism towards psychosis for cannabis users. Expand
The effect of the AKT1 gene and cannabis use on cognitive performance in healthy subjects
TLDR
This study provides additional evidence that AKT1 modulates cognitive performance, however, in the non-clinical sample, the previously reported interaction between cannabis use and theAKT1 gene was not replicated. Expand
The neuropsychological profiles of young psychosis patients with and without current cannabis use
TLDR
No cognitive differences between cannabis-using patients and abstinent patients at the time of illness-onset are demonstrated, providing partial support for an alternative pathway to schizophrenia through early cannabis use. Expand
Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs
TLDR
The association between cannabis and cognition is likely explained by common antecedents, such that genetic and shared environment factors predispose individuals to both cannabis use and cognitive deficits, and to a lesser degree, neurotoxic effects. Expand
Reward, control & decision-making in cannabis use disorder: insights from functional MRI.
TLDR
A snapshot of the current literature assessing the effects of chronic cannabis use on human brain function via functional MRI is presented and studies employing various paradigms and contrasting cognitive activation amongst cannabis users and non-users were incorporated. Expand
Heavy cannabis use, dependence and the brain: a clinical perspective
TLDR
Current evidence of long‐term effects of daily cannabis use and cannabis use disorder on brain‐related outcomes is suggestive rather than conclusive, but use is associated with psychiatric morbidity and with cognitive impairments that recover after a period of abstinence. Expand
Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape
TLDR
Putamen and thalamic enlargement may be related to compulsivity in patients with a history of cannabis use and regional deflations in hippocampus as a neurotoxic effect and regional inflations in striatal regions implicated in addictive processes are seen. Expand
Cannabis-associated psychosis: Neural substrate and clinical impact
TLDR
There is much still to learn about the biological mechanisms underlying how cannabis increases risk of psychosis, but there are plausible biological explanations for the psychotogenic effects of cannabis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 92 REFERENCES
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
TLDR
Effect size differences in cognitive performance in the schizophrenia group as a function of cannabis use were in the small to medium range, denoting superior performance in cannabis-using patients. Expand
Cannabis use and cognitive functions in at-risk mental state and first episode psychosis
TLDR
The results of the present study do not support the notion that FEP patients and ARMS individuals with a history of cannabis use have less impaired cognitive functioning compared to those without cannabis use. Expand
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
TLDR
It is suggested that patients with schizophrenia or FEP with a history of cannabis use have superior neuropsychological functioning compared with nonusing patients and this association between better cognitive performance and cannabis use in schizophrenia may be driven by a subgroup of "neurocognitively less impaired" patients. Expand
Effects of cannabis use status on cognitive function, in males with schizophrenia
TLDR
Examination of cognitive performance as a function of cannabis use patterns in schizophrenia suggests that the state dependent negative effects of cannabis may be reversed with sustained abstinence, and cross-sectional comparisons suggest that lifetime cannabis users demonstrate better processing speed than patients with no lifetime dependence. Expand
The role of cannabis in cognitive functioning of patients with schizophrenia
TLDR
In the view of this study, the better cognitive functioning of SCH + CUD patients may rather reflect a relatively lower vulnerability to psychosis compared to the SCH group, which may correspond to a higher level of functioning such as cognitive ability. Expand
Effect of illegal substance use on cognitive function in individuals with a psychotic disorder: a review and meta-analysis.
TLDR
An overview of the literature that has investigated the effect of illegal substance abuse or dependence on cognitive function in those with a psychotic disorder is given and a meta-analysis shows that substance users performed significantly better than nonusers in the cognitive domains of attention and psychomotor speed and verbal memory. Expand
Cannabis Use and Cognition in Schizophrenia
TLDR
It is suggested that cannabis causes a transient cognitive breakdown enabling the development of psychosis, imitating the typical cognitive vulnerability seen in schizophrenia, and supported by an earlier age of onset and fewer neurological soft signs in the cannabis-related schizophrenia group, suggesting an alternative pathway to psychosis. Expand
Long-term effects of frequent cannabis use on working memory and attention: an fMRI study
TLDR
No evidence was found for long-term deficits in working memory and selective attention in frequent cannabis users after 1 week of abstinence, but frequent cannabis use may affect brain function, as indicated by altered neurophysiological dynamics in the left superior parietal cortex during working memory processing. Expand
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis.
TLDR
Overall, these meta-analyses demonstrate that any negative residual effects on neurocognitive performance attributable to either cannabis residue or withdrawal symptoms are limited to the first 25 days of abstinence and there was no evidence for enduring negative effects of cannabis use. Expand
Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.
TLDR
No positive effects of cannabis on cognitive function were observed, and drug use was not associated with improved neurocognition across most of the subgroup characteristics explored in this sample of schizophrenia patients. Expand
...
1
2
3
4
5
...